CN114788786A - Zwitterionic polymer/amorphous calcium phosphate nano-composite as well as preparation method and application thereof - Google Patents

Zwitterionic polymer/amorphous calcium phosphate nano-composite as well as preparation method and application thereof Download PDF

Info

Publication number
CN114788786A
CN114788786A CN202110925067.6A CN202110925067A CN114788786A CN 114788786 A CN114788786 A CN 114788786A CN 202110925067 A CN202110925067 A CN 202110925067A CN 114788786 A CN114788786 A CN 114788786A
Authority
CN
China
Prior art keywords
zwitterionic polymer
phosphate
solution
amorphous calcium
calcium phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110925067.6A
Other languages
Chinese (zh)
Other versions
CN114788786B (en
Inventor
刘文广
杨建海
魏祥雨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin University
Original Assignee
Tianjin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin University filed Critical Tianjin University
Priority to CN202110925067.6A priority Critical patent/CN114788786B/en
Publication of CN114788786A publication Critical patent/CN114788786A/en
Application granted granted Critical
Publication of CN114788786B publication Critical patent/CN114788786B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/887Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/15Compositions characterised by their physical properties
    • A61K6/17Particle size
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/20Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/60Preparations for dentistry comprising organic or organo-metallic additives
    • A61K6/69Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A61K6/838Phosphorus compounds, e.g. apatite
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00Manufacture or treatment of nanostructures

Abstract

The invention provides a zwitterionic polymer/amorphous calcium phosphate nano-composite, which is prepared by dissolving a zwitterionic polymer in a calcium chloride aqueous solution, and stirring and mixing uniformly to obtain a solution A; dissolving phosphate in water, and stirring to dissolve the phosphate to obtain a solution B; and adding the solution B into the solution A, and stirring for 5-30min at the rotating speed of 400-600rpm to fully react to obtain the zwitter-ion polymer/amorphous calcium phosphate nano-composite. The compound has good biocompatibility, can promote the remineralization of tooth enamel and the occlusion of dentinal tubules in a saliva environment, and can inhibit the adhesion of dental caries bacteria and the formation of bacterial biofilms, thereby realizing the purposes of blocking the progress of dental caries and remineralizing demineralized hard tooth tissues.

Description

Zwitterionic polymer/amorphous calcium phosphate nano-composite as well as preparation method and application thereof
Technical Field
The invention relates to the technical field of biological materials, in particular to a zwitterionic polymer/amorphous calcium phosphate nano composite.
Background
Caries is a bacterial biofilm-dependent disease in which cariogenic bacteria (such as Streptococcus mutans) metabolize carbohydrates by fermentation to produce a pH in the plaque biofilm: (<5.5) demineralization of the hard tissues of the teeth (enamel and dentin) occurs. It has been found that the combined effect of bacteriostasis and remineralization can simultaneously arrest the cariogenic process and prevent new caries. Amorphous Calcium Phosphate (ACP) nanoparticles are capable of releasing large amounts of Ca 2+ And PO 4 3- Ions have great potential in the treatment of enamel demineralization. Spherical ACP nanoparticles can be deposited into chains and then converted to Hydroxyapatite (HA), forming tooth enamel. However, ACP is an unstable substance that readily reacts with atmospheric water in solution or in a dry state, rapidly transforms into a thermodynamically more stable calcium phosphate, and fails to maintain supersaturated Ca for remineralization 2+ 、PO 4 3- And (4) an ionic environment. Studies show that amelogenin (Amel) can stabilize ACP to form Amel/ACP particles and guide the particles to be arranged, fused and converted into HA crystals. Inspired by the capability of amelogenin in stabilizing ACP, researchers speculate that the existence of macromolecules can be used as a stabilizer to directly isolate supersaturated calcium and phosphorus ions in a solution from precipitates, so that the calcium/phosphorus ions are stabilized. Thus, Amorphous Calcium Phosphate (ACP) can be stabilized by forming a nanocomposite, remineralizing demineralized tooth enamel with matrix-stabilized ACP nanoparticles. However, the use of these nanocomposites neglects the presence of cariogenic bacterial biofilms in actual cariogenic demineralization areas and the continuing bacterial challenges in the oral cavity.
Disclosure of Invention
The invention overcomes the defects in the prior art, ignores the existence of cariogenic bacterial biomembranes in actual carious demineralization areas and the persistent bacterial challenges in oral cavities by the application of the existing nano-composites, and provides the zwitterionic polymer/amorphous calcium phosphate nano-composite which has good biocompatibility, can promote the remineralization of tooth enamel and the occlusion of dentinal tubules in a saliva environment, and can inhibit the adhesion of cariogenic bacteria and the formation of bacterial biomembranes, thereby realizing the purposes of blocking the progress of caries and remineralizing demineralized tooth hard tissues.
The purpose of the invention is realized by the following technical scheme.
The zwitterionic polymer/amorphous calcium phosphate nano-composite and the preparation method thereof are carried out according to the following steps:
step 1, dissolving a zwitterionic polymer in a calcium chloride aqueous solution, and stirring and mixing uniformly to obtain a solution A, wherein the zwitterionic polymer has the following chemical structure:
Figure BDA0003208967460000021
in the above formula, R is H or CH 3 ,R 1 Is O or NH, n is 1, 2 or 3, M is 1 or 2, the concentration of the calcium chloride aqueous solution is 0.01-0.1M, and the concentration of the zwitterionic polymer in the solution A is 1-10 wt%;
step 2, dissolving phosphate in water, and stirring and dissolving to obtain a solution B, wherein the phosphate is one of disodium hydrogen phosphate, dipotassium hydrogen phosphate, sodium dihydrogen phosphate and potassium dihydrogen phosphate, and the concentration of a phosphate aqueous solution is 0.01-0.1M;
and 3, adding the solution B prepared in the step 2 into the solution A prepared in the step 1, and stirring for 5-30min at the rotating speed of 400-600rpm to fully react to obtain the zwitterionic polymer/amorphous calcium phosphate nano-composite (PCBAA/ACP).
In step 1, the concentration of the aqueous calcium chloride solution was 0.02M and the concentration of the zwitterionic polymer in solution A was 6 wt%.
In step 1, the zwitterionic polymer is a carboxylic acid type betaine Polymer (PCBAA) with a chemical structure as follows:
Figure BDA0003208967460000022
in step 2, dipotassium hydrogen phosphate was used as the phosphate, and the concentration of the phosphate aqueous solution was 0.06M.
In step 3, stirring was carried out at 500rpm for 10 min.
The invention has the beneficial effects that: the invention provides a novel bionic Amorphous Calcium Phosphate (ACP) nano-composite which is synthesized by stabilizing Amorphous Calcium Phosphate (ACP) nano-particles by adopting a zwitterionic polymer with good biocompatibility, the Amorphous Calcium Phosphate (ACP) nano-particles are chelated by abundant carboxyl on a side chain of the zwitterionic polymer, the Amorphous Calcium Phosphate (ACP) nano-particles in a solution can be stabilized, simultaneously, a charged quaternary ammonium salt group can be used as a nucleation site to mediate the transformation of the Amorphous Calcium Phosphate (ACP) nano-particles to oriented apatite crystals, the effective in-vitro mineralization is realized, meanwhile, the inherent super-hydrophilic property of the zwitterionic polymer endows the Amorphous Calcium Phosphate (ACP) nano-composite to resist bacterial adhesion and bacterial biofilm formation, and the Amorphous Calcium Phosphate (ACP) nano-composite has antibacterial property under an acidic environment caused by a bacterial biofilm, therefore, the zwitterionic polymer/amorphous calcium phosphate nano-composite is a very promising tooth remineralization nano-material, has double functions in preventing caries: 1) an anti-biofilm membrane; 2) promoting remineralization of enamel and occlusion of dentinal tubules.
Drawings
FIG. 1 is a transmission electron microscope image of the zwitterionic polymer/amorphous calcium phosphate nanocomposite (PCBAA/ACP) solution prepared in example 1, with diffraction rings in the upper right corner, (a)1 day, (b)2 days, (c)3 days, (d)4 days, (e)5 days, and (f)7 days;
FIG. 2 is a laser confocal microscope image and a three-dimensional 3D image of a surface biofilm of an enamel specimen treated by the zwitterionic polymer/amorphous calcium phosphate nanocomposite (PCBAA/ACP) solution prepared in example 1, a blank enamel specimen, a carboxylic acid type betaine Polymer (PCBAA) and a zwitterionic polymer/amorphous calcium phosphate nanocomposite (PCBAA/ACP);
FIG. 3 is a scanning electron microscope image of remineralization of enamel and occlusion of dentinal tubules after treatment with the zwitterionic polymer/amorphous calcium phosphate nanocomposite (PCBAA/ACP) solution prepared in example 1, wherein A and B are untreated, acid etched enamel and dentin; c and D are acid-etched enamel and dentin after treatment with zwitterionic polymer/amorphous calcium phosphate nanocomposite (PCBAA/ACP).
Detailed Description
The technical solution of the present invention is further illustrated by the following specific examples.
Example 1
The preparation method of the zwitterionic polymer/amorphous calcium phosphate nano-composite (PCBAA/ACP) comprises the following steps:
s1: dissolving 0.6g of zwitterionic polymer carboxylic acid type betaine Polymer (PCBAA) in 10mL of 0.2M calcium chloride aqueous solution, and stirring at the rotating speed of 500rpm for 10min to obtain a solution A;
s2: weighing 20.88mg of dipotassium hydrogen phosphate, and dissolving the dipotassium hydrogen phosphate in 10mL of deionized water to obtain a solution B;
s3: and slowly adding the solution B into the solution A, and stirring at the rotating speed of 500rpm for 10min to fully react so as to obtain the zwitterionic polymer/amorphous calcium phosphate nano-composite (PCBAA/ACP).
To further investigate the properties of the zwitterionic polymer/amorphous calcium phosphate nanocomposite (PCBAA/ACP) prepared in example 1, this example was subjected to corresponding experimental validation:
as shown in fig. 1, which is a transmission electron micrograph of the material solution, the upper right corner is a diffraction ring, and it can be seen from the micrograph that the zwitterionic polymer/amorphous calcium phosphate nanocomposite (pcba/ACP) solution can be stabilized for 1 day without any aggregation or particle size increase, and in the next two days, although there is a small amount of aggregation and the size of the nanoparticles is slightly increased, they are still amorphous, and in days 4 and 5, the nanoparticles are significantly aggregated, which indicates that the stabilizing effect of the zwitterionic polymer/amorphous calcium phosphate nanocomposite (pcba/ACP) on the Amorphous Calcium Phosphate (ACP) nanoparticles is significantly reduced, but the SAED image of the nanoparticles does not show a significant crystal structure, and after 7 days, the spherical particles disappear and are converted into a needle-like structure, and in this experiment, the carboxylic betaine polymer (pcba) can stabilize the Amorphous Calcium Phosphate (ACP) nanoparticles in the solution for at least 1 day, and the time for aggregating the Amorphous Calcium Phosphate (ACP) nanoparticles into large particles is prolonged by 5 days as a nucleation inhibitor, which is beneficial to the Amorphous Calcium Phosphate (ACP) nanoparticles to penetrate into the deep part of a demineralization area in the remineralization process, and the Amorphous Calcium Phosphate (ACP) nanoparticles are prevented from being rapidly converted into hydroxyapatite crystals before entering gaps.
As shown in fig. 2, which is a laser confocal image of bacterial biofilm on enamel surface, it can be seen that dense bacterial biofilm was formed on the enamel surface without any treatment, the bacteria were active bacteria, and the bacteria in the bacterial biofilm on the enamel surface treated with the zwitterionic polymer/amorphous calcium phosphate nano-complex (PCBAA/ACP) were dead bacteria, indicating that the zwitterionic polymer/amorphous calcium phosphate nano-complex (PCBAA/ACP) can kill the bacteria in the bacterial biofilm.
As shown in figure 3, which is a scanning electron microscope image of enamel remineralization and dentinal tubule occlusion, it can be seen that after treatment with zwitterionic polymer/amorphous calcium phosphate nanocomposite (PCBAA/ACP), the acid etched enamel surface forms a uniform mineral layer and the dentinal tubules are almost completely enclosed, indicating that the material is capable of remineralization of the dental hard tissue.
Example 2
The preparation method of the zwitterionic polymer/amorphous calcium phosphate nano composite comprises the following steps:
s1: dissolving 1.0g of zwitterionic polymer carboxylic acid type betaine Polymer (PCBAA) in 10mL of 0.2M calcium chloride aqueous solution, and stirring at 500rpm for 10min to obtain solution A;
s2: weighing 41.76mg of dipotassium hydrogen phosphate, and dissolving the dipotassium hydrogen phosphate in 10mL of deionized water to obtain a solution B;
s3: and slowly adding the solution B into the solution A, and stirring at the rotating speed of 500rpm for 10min to fully react so as to obtain the zwitterionic polymer/amorphous calcium phosphate nano-composite (PCBAA/ACP).
Example 3
The preparation method of the zwitterionic polymer/amorphous calcium phosphate nano composite comprises the following steps:
s1: dissolving 1.0g of zwitterionic polymer carboxylic acid type betaine Polymer (PCBAA) in 10mL of 0.3M calcium chloride aqueous solution, and stirring at 500rpm for 10min to obtain solution A;
s2: weighing 41.76mg of dipotassium hydrogen phosphate, and dissolving the dipotassium hydrogen phosphate in 10mL of deionized water to obtain a solution B;
s3: and slowly adding the solution B into the solution A, and stirring at the rotating speed of 500rpm for 10min to fully react so as to obtain the zwitterionic polymer/amorphous calcium phosphate nano-composite (PCBAA/ACP).
Example 4
The preparation method of the zwitterionic polymer/amorphous calcium phosphate nano composite comprises the following steps:
s1: dissolving 0.6g of zwitterionic polymer carboxylic acid type betaine Polymer (PCBAA) in 10mL of 0.4M calcium chloride aqueous solution, and stirring at the rotating speed of 500rpm for 10min to obtain a solution A;
s2: weighing 41.76mg of dipotassium hydrogen phosphate, and dissolving the dipotassium hydrogen phosphate in 10mL of deionized water to obtain a solution B;
s3: and slowly adding the solution B into the solution A, and stirring at the rotating speed of 500rpm for 10min to fully react so as to obtain the zwitterionic polymer/amorphous calcium phosphate nano-composite (PCBAA/ACP).
The invention being thus described by way of example, it should be understood that any simple alterations, modifications or other equivalent alterations as would be within the skill of the art without the exercise of inventive faculty, are within the scope of the invention.

Claims (9)

1. A zwitterionic polymer/amorphous calcium phosphate nanocomposite characterized in that: the method comprises the following steps:
step 1, dissolving a zwitterionic polymer in a calcium chloride aqueous solution, and stirring and mixing uniformly to obtain a solution A, wherein the zwitterionic polymer has the following chemical structure:
Figure RE-FDA0003280710500000011
in the above formula, R is H or CH 3 ,R 1 Is O or NH, n is 1, 2 or 3, M is 1 or 2, the concentration of the calcium chloride aqueous solution is 0.01-0.1M, and the concentration of the zwitterionic polymer in the solution A is 1-10 wt%;
step 2, dissolving phosphate in water, stirring and dissolving to obtain a solution B, wherein the phosphate is one of disodium hydrogen phosphate, dipotassium hydrogen phosphate, sodium dihydrogen phosphate and potassium dihydrogen phosphate, and the concentration of a phosphate aqueous solution is 0.01-0.1M;
and 3, adding the solution B prepared in the step 2 into the solution A prepared in the step 1, and stirring for 5-30min at the rotating speed of 400-600rpm to fully react to obtain the zwitterionic polymer/amorphous calcium phosphate nano-composite.
2. The zwitterionic polymer/amorphous calcium phosphate nanocomposite of claim 1, wherein: in step 1, the concentration of the calcium chloride aqueous solution is 0.02M, and in the solution A, the concentration of the zwitterionic polymer is 6 wt%, and the zwitterionic polymer is a carboxylic acid type betaine polymer, and the chemical structure of the zwitterionic polymer is as follows:
Figure RE-FDA0003280710500000012
3. the zwitterionic polymer/amorphous calcium phosphate nanocomposite of claim 1, wherein: in step 2, dipotassium hydrogen phosphate was used as the phosphate, and the concentration of the phosphate aqueous solution was 0.06M.
4. The preparation method of the zwitterionic polymer/amorphous calcium phosphate nano composite is characterized by comprising the following steps: the method comprises the following steps:
step 1, dissolving a zwitterionic polymer in a calcium chloride aqueous solution, and stirring and mixing uniformly to obtain a solution A, wherein the zwitterionic polymer has a chemical structure as follows:
Figure RE-FDA0003280710500000021
in the above formula, R is H or CH 3 ,R 1 Is O or NH, n is 1, 2 or 3, M is 1 or 2, the concentration of the calcium chloride aqueous solution is 0.01-0.1M, and the concentration of the zwitterionic polymer in the solution A is 1-10 wt%;
step 2, dissolving phosphate in water, stirring and dissolving to obtain a solution B, wherein the phosphate is one of disodium hydrogen phosphate, dipotassium hydrogen phosphate, sodium dihydrogen phosphate and potassium dihydrogen phosphate, and the concentration of a phosphate aqueous solution is 0.01-0.1M;
and 3, adding the solution B prepared in the step 2 into the solution A prepared in the step 1, and stirring for 5-30min at the rotating speed of 400-600rpm to fully react to obtain the zwitterionic polymer/amorphous calcium phosphate nano-composite.
5. The method of preparing the zwitterionic polymer/amorphous calcium phosphate nanocomposite of claim 4, wherein: in step 1, the concentration of the calcium chloride aqueous solution is 0.02M, and in the solution A, the concentration of the zwitterionic polymer is 6 wt%, and the zwitterionic polymer is a carboxylic acid type betaine polymer, and the chemical structure of the zwitterionic polymer is as follows:
Figure RE-FDA0003280710500000022
6. the method for preparing the zwitterionic polymer/amorphous calcium phosphate nanocomposite according to claim 4, characterised in that: in step 2, dipotassium hydrogen phosphate is used as phosphate, and the concentration of the phosphate aqueous solution is 0.06M.
7. The method of preparing the zwitterionic polymer/amorphous calcium phosphate nanocomposite of claim 4, wherein: in step 3, stirring was carried out at 500rpm for 10 min.
8. Use of the zwitterionic polymer/amorphous calcium phosphate nanocomposite according to any one of claims 1 to 3 in demineralised dental hard tissue biomimetic remineralisation, caries-blocking drugs and care products thereof.
9. Use according to claim 8, characterized in that: the acid-etched enamel surface treated by the zwitterionic polymer/amorphous calcium phosphate nano-composite forms a uniform mineral layer, dentinal tubules are almost completely closed, and the zwitterionic polymer/amorphous calcium phosphate nano-composite can remineralize hard tissues of teeth.
CN202110925067.6A 2021-08-12 2021-08-12 Zwitterionic polymer/amorphous calcium phosphate nano-composite and preparation method and application thereof Active CN114788786B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110925067.6A CN114788786B (en) 2021-08-12 2021-08-12 Zwitterionic polymer/amorphous calcium phosphate nano-composite and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110925067.6A CN114788786B (en) 2021-08-12 2021-08-12 Zwitterionic polymer/amorphous calcium phosphate nano-composite and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN114788786A true CN114788786A (en) 2022-07-26
CN114788786B CN114788786B (en) 2023-09-26

Family

ID=82459496

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110925067.6A Active CN114788786B (en) 2021-08-12 2021-08-12 Zwitterionic polymer/amorphous calcium phosphate nano-composite and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN114788786B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080039592A1 (en) * 2004-08-11 2008-02-14 Kuraray Medical Inc. Dental Polymerizable Composition
US20090226555A1 (en) * 2004-08-10 2009-09-10 Helixir Co., Ltd. Extract of actinidia arguta for preventing and treating baldness disorders and seborrheic skin disorders
US20130236630A1 (en) * 2012-03-07 2013-09-12 Empire Technology Development Llc Zwitterionic lignin derivatives for marine antifouling coatings
CN106473933A (en) * 2016-10-13 2017-03-08 浙江大学 The biomineralization material of bonding auxiliary and its application in biomimetic mineralization

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090226555A1 (en) * 2004-08-10 2009-09-10 Helixir Co., Ltd. Extract of actinidia arguta for preventing and treating baldness disorders and seborrheic skin disorders
US20080039592A1 (en) * 2004-08-11 2008-02-14 Kuraray Medical Inc. Dental Polymerizable Composition
US20130236630A1 (en) * 2012-03-07 2013-09-12 Empire Technology Development Llc Zwitterionic lignin derivatives for marine antifouling coatings
CN106473933A (en) * 2016-10-13 2017-03-08 浙江大学 The biomineralization material of bonding auxiliary and its application in biomimetic mineralization

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MENG XU 等: "Biomimetic mineralization of a hydroxyapatite crystal in the presence of a zwitterionic polymer", 《CRYSTENGCOMM》, pages 2374 - 2383 *
蔡洪桢 等: "人工种植体表面改性方法研究进展", 《中华老年口腔医学杂志》, pages 237 - 241 *
郭洪刚 等: "新型纳米化仿生骨基质与羊脂肪基质细胞复合培养的生物相容性", 《中国组织工程研究》, pages 2889 - 2892 *

Also Published As

Publication number Publication date
CN114788786B (en) 2023-09-26

Similar Documents

Publication Publication Date Title
AU2013217399B2 (en) Multicomponent oral care composition
Elkassas et al. The innovative applications of therapeutic nanostructures in dentistry
WO2008068247A1 (en) Oral care product
CN107613944A (en) Prepare for prevent and block dental caries damage and make remineralization of teeth product technique, and its prepare product
JP6498116B2 (en) Oral care oral hygiene product having photocatalytic activity, comprising inorganic particles surface-functionalized with TiO2 nanoparticles
Zhang et al. Remineralizing nanomaterials for minimally invasive dentistry
Jerri Al-Bakhsh et al. The antibacterial activity of an epoxy resin-based dental sealer containing bioactive glass, hydroxyapatite, and fluorohydroxyapatite nanoparticles against Enterococcus Faecalis and Streptococcus mitis
CN114788786A (en) Zwitterionic polymer/amorphous calcium phosphate nano-composite as well as preparation method and application thereof
CA3154892A1 (en) Stabilized amorphous calcium magnesium phosphate particle compositions
Hannig et al. Nanobiomaterials in preventive dentistry
BR112019001796B1 (en) Oral care composition, method of sensitivity reduction and/or remineralization and/or teeth whitening, and use of oral care composition
US20140161852A1 (en) Nanoparticle dental composition and method of making
Baiju et al. Nanotechnology for Oral Disease Prevention
EP3484435A1 (en) Oral care composition comprising composite particles containing cationic germicide
Handa et al. Scope of nanotechnology in dentistry-A review of literature
Yahya et al. Nanoparticles as Endodontic Irrigation: An Update Overview
Liao et al. Stimuli-responsive graphdiyne-silver nanozymes for catalytic ion therapy of dental caries through targeted biofilms removal and remineralization
Jabin et al. Novel approaches in hard tissue remineralization: an overview
EP3542776B1 (en) Metal-carbon structure hybrid formulation for dental use in the treatment of dental hypersensitivity, demineralisation and cavities
WO2023203578A1 (en) Nanostructure, nanocomposite, and implementations thereof
WO2008022858A2 (en) System comprising a) poorly water-soluble calcium salts and/or composite materials containing the same, and b) easily water-soluble calcium salts and/or phosphate salts
Chakraborty et al. Role of Nanotechnology in Dental Decay: A Review
CN111714385A (en) Formula and application of composite micro-nano particles
Xu et al. Polyelectrolyte‐Cation Complexes Using PAsp‐Sr Complexes Induce Biomimetic Mineralization with Antibacterial Ability
Jurczyka et al. Nanomaterials in Preventive Dentistry

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant